Latest profit margin for REYON Pharmaceutical , Ltd.: -24.02% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), 102460.KS shows a profit margin of -24.02%. That compares with -6.51% in the prior-year period — down 269.1% year over year. That is below the sector sector average of 13.4%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, 102460.KS's profit margin is now -24.02% (was -6.51%) — a 269.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether REYON Pharmaceutical , Ltd. is outperforming or lagging.
The its sector sector average profit margin is about 13.4%. REYON Pharmaceutical , Ltd. is at -24.02%, which is lower that average. That is roughly 279.2% below the sector mean. Use the comparison chart on this page to see how 102460.KS stacks up against individual peers as well.
That compares with -6.51% in the prior-year period — down 269.1% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare REYON Pharmaceutical , Ltd. with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has REYON Pharmaceutical , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -24.02%) with ownership activity and broader fundamentals.